Investor Alert

London Markets Open in:

Revolution Medicines Inc.



After Hours

 --Quotes are delayed by 20 min

Oct 4, 2022, 4:02 p.m.





0.00 0.00%


Volume 169,529

Quotes are delayed by 20 min


Previous close

$ 19.53

$ 20.00


+0.47 +2.41%

Day low

Day high




52 week low

52 week high




Sushil Patel

Sushil Patel is on the board of Revolution Medicines, Inc. and Chief Commercial Officer at Replimune Group, Inc.

In his past career he occupied the position of Vice President-Franchise & Head-Oncology at Genentech, Inc.

Dr. Patel received a graduate degree from Imperial College London, a doctorate from the University of London and an undergraduate degree from the University of Warwick.


Date Shares Transaction Value
06/16/2022 10,500   Award at $0 per share. 0

Officers and Executives

Dr. Mark A. Goldsmith
Chairman, President & Chief Executive Officer
Dr. Margaret A. Horn
Chief Operating Officer & General Counsel
Mr. Jack Anders
Chief Financial Officer
Dr. Stephen M. Kelsey
President-Research & Development
Dr. Walter Reiher
Chief Information Officer
Dr. Xiao Lin Wang
Executive Vice President-Clinical Development
Dr. Sushil Patel
Ms. Luan M. Wilfong
Senior Vice President-Human Resources
Mr. Jeff Cislini
Secretary, Senior Vice President & General Counsel
Dr. Eric Schmidt
Independent Director
Dr. Flavia Borellini
Independent Director
Dr. Lorence H. Kim
Independent Director
Ms. Elizabeth McKee Anderson
Independent Director
Mr. Alexis A. Borisy
Lead Independent Director
Dr. Thilo Schroeder
Independent Director
Dr. Barbara L. Weber
Independent Director
Link to MarketWatch's Slice.